Circulating Biomarker Discovery Through Liquid Biopsy Multi-Omics Integration
This research mines multi-omics datasets from circulating tumor DNA, RNA, proteins, and exosomes to identify minimally invasive biomarkers for cancer detection, monitoring, and treatment response. The integrated approach establishes clinically actionable liquid biopsy signatures for early diagnosis and real-time disease tracking.